Skip to main content
Premium Trial:

Request an Annual Quote

Biofortuna to Use TriLink dNTPs in Diagnostic PCR Kits

Premium

TriLink BioTechnologies said this week that it has signed a licensing agreement with Biofortuna for use of its CleanAmp dNTPs in Biofortuna's freeze-dried in vitro diagnostic PCR kits.

Biofortuna will use the dNTPs for a line of human leukocyte antigen diagnostic kits it is developing for the transplantation, blood grouping, disease identification, and pharmacogenetic markets. The company is targeting its first product for the sequence-specific primer transplantation market.

TriLink said that Biofortuna was able to improve the specificity of its genotyping assays by replacing standard dNTPs with CleanAmp dNTPs.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.